PARTNER NEWS:Tue, Jan 27, 9:53 AM, Zacks
RVMD Stock Tumbles as MRK Reportedly Withdraws Buyout Offer
Revolution Medicines stock tanks after a WSJ report said Merck has withdrawn from buyout talks over price.
Fri, Jan 9, 11:03 AM, Zacks
Merck in Talks to Buy Revolution Medicines Per Financial Times Report
Merck is in talks to acquire RVMD, which could bolster its oncology pipeline, according to a Financial Times report.